Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis Journal Article


Authors: Tanaka, K.; Yu, H. A.; Yang, S.; Han, S.; Selcuklu, S. D.; Kim, K.; Ramani, S.; Ganesan, Y. T.; Moyer, A.; Sinha, S.; Xie, Y.; Ishizawa, K.; Osmanbeyoglu, H. U.; Lyu, Y.; Roper, N.; Guha, U.; Rudin, C. M.; Kris, M. G.; Hsieh, J. J.; Cheng, E. H.
Article Title: Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
Abstract: The clinical success of EGFR inhibitors in EGFR-mutant lung cancer is limited by the eventual development of acquired resistance. We hypothesize that enhancing apoptosis through combination therapies can eradicate cancer cells and reduce the emergence of drug-tolerant persisters. Through high-throughput screening of a custom library of ∼1,000 compounds, we discover Aurora B kinase inhibitors as potent enhancers of osimertinib-induced apoptosis. Mechanistically, Aurora B inhibition stabilizes BIM through reduced Ser87 phosphorylation, and transactivates PUMA through FOXO1/3. Importantly, osimertinib resistance caused by epithelial-mesenchymal transition (EMT) activates the ATR-CHK1-Aurora B signaling cascade and thereby engenders hypersensitivity to respective kinase inhibitors by activating BIM-mediated mitotic catastrophe. Combined inhibition of EGFR and Aurora B not only efficiently eliminates cancer cells but also overcomes resistance beyond EMT. © 2021 Elsevier Inc.
Keywords: apoptosis; epidermal growth factor receptor; lung cancer; drug resistance; drug tolerance; aurora b kinase; emt; bcl-2 family; mitotic catastrophe; lineage plasticity
Journal Title: Cancer Cell
Volume: 39
Issue: 9
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2021-09-13
Start Page: 1245
End Page: 1261.e6
Language: English
DOI: 10.1016/j.ccell.2021.07.006
PUBMED: 34388376
PROVIDER: scopus
PMCID: PMC8440494
DOI/URL:
Notes: Article -- Export Date: 1 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Emily H Cheng
    78 Cheng
  3. Mark Kris
    869 Kris
  4. Charles Rudin
    488 Rudin
  5. Kwanghee   Kim
    43 Kim
  6. Song   Han
    9 Han
  7. Yuchen Xie
    6 Xie
  8. Kosuke Tanaka
    2 Tanaka
  9. Shriram Ramani
    1 Ramani
  10. Allison Moyer
    2 Moyer
  11. Sonali Sinha
    6 Sinha
  12. Shaoyuan Yang
    2 Yang